Searched for
STRIDES ACROLABS
India Inc's foreign investment down 3% to $1.86 bn in JuneIndian companies had invested $1.92 billion in their overseas ventures in June 2015.- Foreign Investment Promotion Board to take up 25 foreign direct investment proposals on September 22FIPB will take up 25 FDI proposals, including those of Aditya Birla Nuvo, Cipla, Sun Pharma Advanced Research and HDFC Capital Advisors
- Strides Acrolab Singapore gets International Headquarters status by EDBStrides Pharma Global will be building a new manufacturing facility in Singapore in next couple of years with focus on regulated & SE Asia ...
- India Inc invests $1.25 billion overseas in August, down 49%The investments were a mix of issuance of guarantees ($ 742.80 million), loans ($ 303.48 million) and of equity ($ 207.39 million).
- Agila Specialties recalls anaesthetic injection in USAgila Specialties, now a part of Mylan Inc, is recalling 10 lots of Etomidate injection, used in general anaesthesia in the US.
- Strides Arcolab plunges over 15% on completion of Agila saleThe pharmaceutical company said it has completed sale of its Agila Specialties Division to Mylan Inc for a total consideration of up to $1....
- Strides completes $1.75 billion sale of Agila Specialties to MylanStrides Arcolab said it has completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to $1.75 bill...
- Strides Arcolabs' Agila Specialties Pharma Corporation forms JV with Jamp PharmaStrides Arcolabs' injectable drug division Agila Specialties Pharma Corporation has formed a 70:30 JV with Jamp Pharma to introduce injecta...
- Strides Acrolab buys injectable facility for Rs 125 croreStrides Arcolab's wholly-owned subsidiary Agila Specialities acquired Sterile Formulations facility located at Hosur from Star Drugs and Re...
- Stocks: The hits and missesShares of software exporters tumbled after US-based Oracle, the third biggest software maker, reported disappointing quarterly results.
- Strides to raise $200 m for debt recast, refinance payoutStrides will soon choose between a private equity placement and a convertible bond issue to raise the first $125 million, a person familiar...
- Strides Acrolab: Drug licence, supply gains turn it onTHE Bangalore-based pharma major, Strides Arcolab, saw its stock price rising by 8% on Wednesday on the back of news of the company collabo...
- Strides Arcolabs looks to seal more drug supply deals with global pharma cosStrides Acrolabs is discussing drug supply deal for niche therapeutics areas with global drug pharma companies.
- General Atlantic eyes stake in Strides armPrivate equity firm General Atlantic (GA) is in advanced talks with Strides Arcolabs to buy a significant minority stake in the Bangalore-b...
- Natco in talks with pharma retail chainsHyderabad-based drug company Natco Pharma, which launched its anti-HINI drug 'Natflu' in the national capital, said it is talking with vari...
- Three cos bag Rs 92-lakh swine flu drug orderRanbaxy Labs, Hetero Drugs and Strides Acrolabs have together bagged orders to supply 92-lakh capsules of generic or low-priced version of ...
- Makers of Tamiflu version see share prices surgeShare price of drug companies Ranbaxy, Natco and Strides Acrolabs, that make low-priced versions of anti-flu medicine Tamiflu, surged on Tu...
- Strides Arcolab ready to supply Swine Flu drugDrug firm Strides Acrolab on Tuesday said it is in a position to supply Oseltamivir Capsules, the only available medicine against Influenza...
- Strides Acrolab receives US FDA approvalThe Rs 1000 crore generic pharma company has received US FDA inspection approval status for its steriles injectable complex at Bangalore.
- Tatas explore tie up with US co for defence equipmentThe Tata group is looking at a tie up with Microbotics, a US aerospace research and development company, to bring its products to India, an...
Load More
